Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo-controlled, Double-blind, Randomized Study of Aerucin® as Adjunct Therapy to Antibiotics in the Treatment of P. Aeruginosa Pneumonia

NCT03027609 is registered in ClinicalTrials.gov with Aridis Pharmaceuticals, Inc. as lead sponsor.

NCT NCT03027609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03027609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo-controlled, Double-blind, Randomized Study of Aerucin® as Adjunct Therapy to Antibiotics in the Treatment of P. Aeruginosa Pneumonia
Lead sponsor
Aridis Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 29, 2017
Completion date
April 25, 2019
Enrollment
158 (actual)
Sites
111

Conditions

As the registry lists them; a condition with its own page is linked.

pseudomonas aeruginosa pneumonia